Skip to main content

Reactions Weekly

Ausgabe 1/2024

Inhalt (221 Artikel)

Case report

Adalimumab/infliximab

Case report

Afatinib

Case report

Alcohol

Case report

Alectinib

Case report

Allopurinol

Case report

Alteplase

Case report

Amiloride

Case report

Amlodipine/phenytoin

Case report

Antibacterials

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antituberculars

Case report

Apalutamide

Case report

Arginine

Case report

Armodafinil/Ketamine

Case report

Articaine/prilocaine

Case report

Asparaginase

Case report

Atezolizumab

Case report

Atomoxetine

Case report

Axitinib

Case report

AZD-1222

Case report

AZD-1222

Case report

BBIBP-CorV

Case report

Bevacizumab

Case report

Botulinum-Toxin-A

Case report

Bupivacaine

Case report

Cabozantinib

Case report

Casirivimab/imdevimab

Case report

Celecoxib

Case report

Celecoxib/sorafenib

Case report

Cemiplimab

Case report

Cisplatin

Case report

Cisplatin/Docetaxel

Case report

Clopidogrel

Case report

Clopidogrel

Case report

Clozapine

Case report

Deflazacort

Case report

Dexamethasone

Case report

Diazoxide

Case report

Dupilumab

Case report

Elasomeran

Case report

Elasomeran

Case report

Erlotinib/osimertinib

Case report

Felbamate

Case report

Fludrocortisone

Case report

Gabapentin

Case report

Gadopentetic-acid

Case report

Golimumab

Case report

Haloperidol

Case report

Heparin/Streptokinase

Case report

Hydrochlorothiazide

Case report

Hydrocortisone

Case report

Hydrocortisone

Case report

Ibrutinib

Case report

Imatinib

Case report

Insulin

Case report

Interferon-alpha

Case report

Iodine-radioactive

Case report

Ipilimumab/nivolumab

Case report

Levodopa/carbidopa

Case report

Levothyroxine-sodium

Case report

Liraglutide

Case report

Lisinopril/nivolumab

Case report

Magnesium sulfate

Case report

Melphalan

Case report

Methotrexate

Case report

Methotrexate

Case report

Methotrexate

Case report

Methotrexate

Case report

Methylprednisolone

Case report

Mitragyna speciosa

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Mutliple drugs

Case report

Mycophenolate-mofetil

Case report

Nivolumab

Case report

Nivolumab

Case report

Olaparib

Case report

Paracetamol

Case report

Pazopanib

Case report

Pegaspargase

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Phenytoin

Case report

Polymixin-B

Case report

Polyvinyl alcohol

Case report

Prednisolone

Case report

Prednisone

Case report

Prednisone/tacrolimus

Case report

Remdesivir

Case report

Rituximab

Case report

Rivaroxaban

Case report

Sodium-phenylbutyrate

Case report

Sugammadex

Case report

Tacrolimus

Case report

Telbivudine

Case report

Temozolomide

Case report

Thiamylal-sodium

Case report

Torasemide

Case report

Tozinameran

Case report

Tozinameran

Case report

Tozinameran

Case report

Tozinameran

Case report

Trastuzumab

Case report

V-503

Case report

Valproic-acid

Case report

Voriconazole

Case report

Warfarin

Case report

Zoledronic-acid

Case report

Zopiclone